Kestra Medical Technologies Quarterly Cash Flow Statement
NASDAQ: KMTSHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kestra Medical Technologies free cash flow
In the quarter ended Jul 31, 2026, Kestra Medical Technologies generated -$32.3 million of operating cash flow and spent $8.3 million on capital expenditures. That left free cash flow of -$40.6 million, a free-cash-flow margin of -131.2% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Kestra Medical Technologies cash flow statement (quarterly)
| Quarter (USD) | Q1 20262026-07-31 | Q4 20262026-04-30 | Q3 20262026-01-31 | Q2 20252025-10-31 | Q1 20252025-07-31 | Q4 20252025-04-30 | Q3 20252025-01-31 | Q2 20252024-10-31 | Q1 20252024-07-31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -44.09M | -38.84M | -34.17M | -32.78M | -25.83M | -51.11M | -21.76M | -20.62M | -20.32M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 2.66M | 2.33M | 1.98M | 2.37M | 2.03M | 1.84M | 1.89M | 1.87M | 2.38M |
| Stock-Based Compensation | 9.52M | 10.30M | 10.11M | 8.65M | 4.58M | 22.31M | 459.00K | 1.12M | 377.00K |
| Change in Working Capital | -1.68M | 1.05M | -1.47M | -368.00K | -4.53M | -3.21M | 288.00K | -3.85M | -1.01M |
| Operating Cash Flow | -32.30M | -18.72M | -18.37M | -18.34M | -26.27M | -24.06M | -18.00M | -18.06M | -17.50M |
| Capital Expenditures | -8.34M | -9.66M | -9.80M | -7.26M | -8.17M | -7.39M | -4.06M | -4.45M | -7.04M |
| Investing Cash Flow | -21.35M | -172.71M | -14.92M | -7.42M | -8.23M | -7.40M | -4.45M | -4.42M | -7.03M |
| Debt Issued | 75.00M | — | — | — | — | — | — | — | — |
| Debt Repaid | -46.40M | — | — | — | — | — | — | — | — |
| Financing Cash Flow | 22.50M | -185.00K | 149.18M | -27.00K | -1.88M | 214.70M | -119.00K | -575.00K | 116.25M |
| Net Change in Cash | -31.15M | -191.61M | 115.90M | -25.79M | -36.38M | 183.24M | -22.57M | -23.05M | 91.72M |
| Free Cash Flow | -40.63M | -28.38M | -28.16M | -25.61M | -34.44M | -31.45M | -22.06M | -22.50M | -24.54M |
This table shows 9 quarterly periods of Kestra Medical Technologies's cash flow statement, from Q1 2026 back to Q1 2025, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow KMTS's reporting calendar. What is a cash flow statement?